Evaluation of essential oils from Boswellia sacra and Teucrium mascatense against acetyl cholinesterase enzyme and urease enzyme
Keywords:Boswellia sacra, Teucrium mascatense, essential oil, acetylcholinesterase enzyme, urease enzyme, ( )-α- pinene
Enzyme inhibition is one of the most important areas of pharmaceutical research which resulted in the discoveries of several useful drugs. The prime aim of this study is to identify effective natural inhibitors against pharmacologically important enzymes such as acetylcholinesterase enzyme and urease enzyme. In present study, we evaluated the essential oils extracted from medicinally important plants including Boswellia sacra Flückiger (frankincense) and Teucrium mascatense Boiss. Two major constituents of frankincense essential oil including (+)-α-pinene and (R)-+-limonene were also investigated against these enzymes. The essential oils were extracted from Boswellia sacra and Teucrium mascatense which are native plants to the southern and northern areas of Oman, respectively. In this study, the essential oil of frankincense exhibited significant inhibition with IC50 value of 0.043±0.02 mg/mL, against acetylcholinesterase enzyme while against urease enzyme it has shown good inhibition with IC50 value of 0.17 ± 0.05 mg/mL. The essential oil obtained from the Teucrium mascatense was found to be in active against both the enzymes. On acetylcholinesterase enzyme inhibition assay, the (+)-α- pinene exhibited significant inhibition (IC50 = 0.094±0.01 mg/mL) while (R)-+- limonene was found to be inactive on this assay. Against urease enzyme (+)-α- pinene and (R)-+- limonene showed moderate activity 40.06±1.03 % and 19.5±1.00 %, respectively. Interestingly, the mixture of equal concentration of (+)-α- pinene and (R)-+- limonene exhibited 70% inhibition with IC50 value of (0.195 ± 0.10 mg/mL) which shows the synergistic relationship between them. Promising inhibitory potential of frankincense essential oil and (+)-α-pinene, against acetylcholinesterase enzyme and urease enzyme indicated their potential therapeutic role to manage Alzheimer’s disease and stomach ulcers, respectively.
. Al-Harrasi A, Al-Saidi S. Phytochemical analysis of the essential oil from botanically certified oleogum resin of Boswellia sacra (Omani Luban). Molecules. 2008;13(9):2181-9.
. Coppi A, Cecchi L, Selvi F, Raffaelli M. The Frankincense tree (Boswellia sacra, Burseraceae) from Oman: ITS and ISSR analyses of genetic diversity and implications for conservation. Genet Resour Crop Evol 2010;57(7):1041-52.
. Suhail MM, Wu W, Cao A, Mondalek FG, Fung KM, Shih PT, Fang YT, Woolley C, Young G, Lin HK. Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells. BMC Complement Altern Med. 201;11(1):1.
. Ni X, Suhail MM, Yang Q, Cao A, Fung KM, Postier RG, Woolley C, Young G, Zhang J, Lin HK. Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model. BMC Complement Altern Med.2012;12(1):1.
. Wahab SM, Aboutabl EA, El-Zalabani SM, Fouad HA, De Pooter HL, El-Fallaha B. The essential oil of olibanum. Planta Med. 1987;53(4):382-4.
. Miller AG, Morris M. Plants of Dhofar: the southern region of Oman, traditional, economic and medicinal uses. Oman: Office of the Adviser for Conservation of the Environment, Diwan of Royal Court Sultanate of Oman xxvii, 1988;361.
. Al-Harrasi A, Ali L, Rehman NU, Hussain H, Hussain J, Al-Rawahi A, Langley GJ, Wells NJ, Abbas G. Nine triterpenes from Boswellia sacra Flückiger and their chemotaxonomic importance. Biochem Syst Ecol 2013;51:113-6.
. Mikhaeil BR, Maatooq GT, Badria FA, Amer M. Chemistry and immunomodulatory activity of frankincense oil. Z Naturforsch C. 2003;58(3-4):230-8.
. Mandaville Jr JP. editor Bovey D, wild flowers of northern Oman. London: Bartholomew 1978.;2. 64p.
. Hisham A, Pathare N, Al-Saidi S, Al-Salmi A. The composition and antimicrobial activity of leaf essential oil of Teucrium mascatenses Boiss. from Oman. Journal of Essential Oil Research. 2006;18(4):465-8.
. Copeland RA. Evaluation of enzyme inhibitors in drug discovery: a guide for medicinal chemists and pharmacologists. Methods Biochem Anal. 2005;46:1-265.
. Perry EK. The cholinergic hypothesis—ten years on. British Medical Bulletin. 1986;42(1):63-9.
. Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982;217(4558):408-14.
. Adewusi EA, Moodley N, Steenkamp V. Antioxidant and acetylcholinesterase inhibitory activity of selected southern African medicinal plants. S. Afr. J. Bot 2011;77(3):638-44.
. Colovic MB, Krstic DZ, Lazarevic-Pasti TD, Bondzic AM, Vasic VM. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol 2013;11(3):315-35.
. Pratt J.P. Affective disorders In: Walker R, Edwards C, editors. Clinical Pharmacy and Therapeutics. 2 nd ed. Edinburgh,Churchill Livingstone, 1999. 409-425.
. Heinrich M, Teoh HL. Galanthamine from snowdrop—the development of a modern drug against Alzheimer’s disease from local Caucasian knowledge. J Ethnopharmacol. 2004;92(2):147-62.
. Das A, Shanker G, Nath C, Pal R, Singh S, Singh HK. A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba: anticholinesterase and cognitive enhancing activities. Pharmacol Biochem Behav. 2002;73(4): 893-900.
. Orhan I, Şener B, Choudhary MI, Khalid A. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plants. J Ethnopharmacol. 2004;91(1):57-60.
. Perry NS, Houghton PJ, Theobald A, Jenner P, Perry EK. In-vitro Inhibition of Human Erythrocyte Acetylcholinesterase by Salvia lavandulaefolia Essential Oil and Constituent Terpenes. J Pharm Pharmacol. 2000;52(7):895-902.
. Perry NS, Houghton PJ, Sampson J, Theobald AE, Hart S, Lis-Balchin M, Hoult JR, Evans P, Jenner P, Milligan S, Perry EK. In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. J Pharm Pharmacol. 2001;53(10):1347-56.
. Mukherjee PK, Kumar V, Mal M, Houghton PJ. Acetylcholinesterase inhibitors from plants. Phytomedicine. 2007 Apr 10;14(4):289-300.
. Andrews RK, Blakeley RL and Zerner B. Urea and urease. Advances in inorganic biochemistry, Eichhorn GL, Marzilli LG, editors. New York,1984. 245-283.
. Ghous T, Akhtar K, Choudhry MA. Screening of selected medicinal plants for urease inhibitory activity. Biol Med. 2010;2(4):64-9.
. Houimel M, Mach JP, Corthésy-Theulaz I, Corthesy B, Fisch I. New inhibitors of Helicobacter pylori urease holoenzyme selected from phage-displayed peptide libraries. Eur J Biochem. 1999;262(3):774-80.
. Calinescu I, Gavrila AI, Ivopol M, Ivopol GC, Popescu M, Mircioaga N. Microwave assisted extraction of essential oils from enzymatically pretreated lavender (Lavandula angustifolia Miller). Cent. Eur J Chem. 2014;12(8):829-36.
. Hussain J, Rehman NU, Al-Harrasi A, Ali L, Khan AL, Albroumi MA. Essential oil composition and nutrient analysis of selected medicinal plants in Sultanate of Oman. Asian Pac J Trop Dis 2013;3(6):421-8.
. Cardoso-Ugarte GA, Juárez-Becerra GP, Sosa-Morales ME, López-Malo A. Microwave-assisted extraction of essential oils from herbs. J Microw Power Electromagn Energy. 2013;47:63-72.
. Eldeen IM, Elgorashi EE, Van Staden J. Antibacterial, anti-inflammatory, anti-cholinesterase and mutagenic effects of extracts obtained from some trees used in South African traditional medicine. J Ethnopharmacol 2005;102(3):457-64.
. Ferreira A, Proença C, Serralheiro ML, Araujo ME. The in vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Portugal. Journal of ethnopharmacology. 2006;108(1):31-7.
. Serwar M, Akhtar T, Hameed S, Khan KM. Synthesis, urease inhibition and antimicrobial activities of some chiral 5-aryl-4-(1-phenylpropyl)-2H-1, 2, 4-triazole-3 (4H)-thiones. Arkivoc. 2009;7:210-21.
. Thulin M, Warfa AM. The frankincense trees (Boswellia spp., Burseraceae) of northern Somalia and southern Arabia. Kew Bulletin. 1987:487-500.